Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00339508 · ClinicalTrials.gov registry record

Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
13,385
Enrollment target

NCT00339508: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00339508 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 13,385 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00339508 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
13,385 participants
Enrollment target

Study Summary

The researchers have developed and distributed several software packages for pedigree analysis (FAST, CASPAR, PedHunter, IIC) and cancer genetics (oncotree, METREX). Users who need assistance with the software or who want to see new features added often send the researchers data files that include human data. The information is normally coded, and the researchers do not have access to the identification of the people whose information is in the files. Sometimes the content of the files gives rise to collaborations between the software developers and the providers of the files. Because concerns over the confidentiality of medical information have increased significantly over the past few years, the researchers must apply for exemptions from detailed ethics committee oversight for every data set they receive. This process is cumbersome and makes it difficult to assist software users. The amount of information required to apply for an exemption also poses a barrier to collaborations. A full protocol will subject all data sets to ethics committee oversight without the need for individual exemption requests, enabling the researchers to assist users with software problems and to collaborate with other researchers. From January 1, 2000, through December 15, 2001, the researchers received 71 requests for assistance, 19 of which included data files. None of the data files had any names or patient identifiers. Of these 19, in 8 cases the researchers sent back modified output files. In two of these eight cases, the researchers could see results of research interest; one of them concerned human data. In 2 of the 19 cases, the researchers sent back modified input files; in one such case, they established a collaboration with the originator of the files. In sum, most requests come under the heading of customer service, with no research contents. A few, however, do lead to research results or collaborations, for which ethics committee oversight is required. Over the three-year

Trial Details

FieldValue
Enrollment Target 13,385 participants
Start Date 2002-03-19
Est. Completion 2017-05-09

What the finished NCT00339508 record still lists

NCT00339508 is an observational study that tracks outcomes without assigning an intervention. Its 13,385 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00339508 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00339508 about?

NCT00339508 is a clinical study titled "Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics". The researchers have developed and distributed several software packages for pedigree analysis (FAST, CASPAR, PedHunter, IIC) and cancer genetics (oncotree, METREX). Users who need assistance with the software or who want to see new features added often send the researchers data files that include h...

What is the current status of trial NCT00339508?

This trial is currently completed. The enrollment target is 13,385 participants. The study started on 2002-03-19. Estimated completion is 2017-05-09.

Who is sponsoring clinical trial NCT00339508?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05141396 · 13,400 participants · NA

    Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

  • NCT06058767 · 13,764 participants · NA

    Preschool Hearing Screening

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00339508, the US trial registry maintained by the National Library of Medicine. NCT00339508 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.